MPS3D
MCID: MCP046
MIFTS: 32

Mucopolysaccharidosis, Type Iiid (MPS3D)

Categories: Bone diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Respiratory diseases, Skin diseases

Aliases & Classifications for Mucopolysaccharidosis, Type Iiid

MalaCards integrated aliases for Mucopolysaccharidosis, Type Iiid:

Name: Mucopolysaccharidosis, Type Iiid 58 41
Mucopolysaccharidosis Type Iiid 58 54 60 76 13
Mps Iiid 58 54 76 56
Mps3d 58 54 60 76
Glucosamine N-Acetyl-6-Sulfatase Deficiency 54 60
N-Acetylglucosamine-6-Sulfatase Deficiency 58 76
Mucopolysaccharidosis Type 3d 54 60
Sanfilippo Syndrome Type D 54 60
Sanfilippo Syndrome D 58 54
Gns Deficiency 54 60
Mpsiiid 54 60
N-Acetylglucosamine-6-Sulfate Sulfatase Deficiency 54
N-Acetylglucosamine-6-Sulfatase 13
Mucopoly-Saccharidosis Type 3d 54
Mucopolysaccharidosis 3d 76
Sanfilippo D Syndrome 76
Mps Iii-D 77
Mps Iii D 74
Mps 3d 54

Characteristics:

Orphanet epidemiological data:

60
sanfilippo syndrome type d
Inheritance: Autosomal recessive;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
progressive disorder
four clinically indistinguishable biochemically distinct forms (see )


HPO:

33
mucopolysaccharidosis, type iiid:
Onset and clinical course progressive
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Mucopolysaccharidosis, Type Iiid

NIH Rare Diseases : 54 Mucopolysaccharidosis type IIID (MPS IIID) is an genetic disorder that makes the body unable to break down large sugar molecules called glycosaminoglycans (GAGs, formerly called mucopolysaccharides). Specifically, people with this condition are unable to break down a GAG called heparan sulfate. Affected individuals can have severe neurological symptoms, including progressive dementia, aggressive behavior, hyperactivity, seizures, deafness, loss of vision, and an inability to sleep for more than a few hours at a time. MPS IIID is caused by the missing or deficient enzymeN-acetylglucosamine 6-sulfatase. MPS IIID is inherited in an autosomal recessive manner. There is no specific treatment for this condition. Most people with MPS IIID live into their teenage years, and some live longer.

MalaCards based summary : Mucopolysaccharidosis, Type Iiid, also known as mucopolysaccharidosis type iiid, is related to mucopolysaccharidosis iii and mucopolysaccharidosis-plus syndrome, and has symptoms including seizures, joint stiffness and diarrhea. An important gene associated with Mucopolysaccharidosis, Type Iiid is GNS (Glucosamine (N-Acetyl)-6-Sulfatase). Affiliated tissues include bone, eye and skin, and related phenotypes are low-set ears and short neck

OMIM : 58 The mucopolysaccharidoses are a family of lysosomal storage diseases caused by deficiencies of enzymes required for the catabolism of glycosaminoglycans. The defects result in accumulation of excessive intralysosomal glycosoaminoglycans (mucopolysaccharides) in various tissues, causing distended lysosomes to accumulate in the cell and interfere with cell function. Multiple types have been described (Mok et al., 2003). (252940)

UniProtKB/Swiss-Prot : 76 Mucopolysaccharidosis 3D: A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life.

Wikipedia : 77 Sanfilippo syndrome, is a rare autosomal recessive lysosomal storage disease. It is caused by a... more...

Related Diseases for Mucopolysaccharidosis, Type Iiid

Symptoms & Phenotypes for Mucopolysaccharidosis, Type Iiid

Human phenotypes related to Mucopolysaccharidosis, Type Iiid:

33 (show all 35)
# Description HPO Frequency HPO Source Accession
1 low-set ears 33 HP:0000369
2 short neck 33 HP:0000470
3 frontal bossing 33 HP:0002007
4 intellectual disability 33 HP:0001249
5 seizures 33 HP:0001250
6 dysarthria 33 HP:0001260
7 dysphagia 33 HP:0002015
8 sleep disturbance 33 HP:0002360
9 coarse facial features 33 HP:0000280
10 hearing impairment 33 HP:0000365
11 splenomegaly 33 HP:0001744
12 hepatomegaly 33 HP:0002240
13 depressed nasal bridge 33 HP:0005280
14 joint stiffness 33 HP:0001387
15 anteverted nares 33 HP:0000463
16 thick eyebrow 33 HP:0000574
17 coarse hair 33 HP:0002208
18 flexion contracture 33 HP:0001371
19 dysostosis multiplex 33 HP:0000943
20 prominent forehead 33 HP:0011220
21 thick lower lip vermilion 33 HP:0000179
22 recurrent upper respiratory tract infections 33 HP:0002788
23 absent speech 33 HP:0001344
24 wide mouth 33 HP:0000154
25 diarrhea 33 HP:0002014
26 synophrys 33 HP:0000664
27 hyperactivity 33 HP:0000752
28 drooling 33 HP:0002307
29 hirsutism 33 HP:0001007
30 ovoid thoracolumbar vertebrae 33 HP:0003309
31 thickened ribs 33 HP:0000900
32 asymmetric septal hypertrophy 33 HP:0001670
33 heparan sulfate excretion in urine 33 HP:0002159
34 growth abnormality 33 HP:0001507
35 cellular metachromasia 33 HP:0003653

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Ears:
low-set ears
hearing loss

Neurologic Central Nervous System:
seizures
dysarthria
hyperactivity
mental retardation
sleep disturbances common
more
Head And Neck Face:
coarse facial features
prominent forehead

Skin Nails Hair Hair:
coarse hair
synophrys
hirsutism
thick eyebrows

Head And Neck Eyes:
synophrys
decreased vision
clear corneas

Skeletal:
joint contractures
mild dysotosis multiplex

Abdomen Spleen:
mild splenomegaly

Chest Ribs Sternum Clavicles And Scapulae:
thick ribs

Abdomen Liver:
mild hepatomegaly

Laboratory Abnormalities:
heparan sulfate excretion in urine
metachromasia of white blood cells and fibroblasts
n-acetylglucosamine-6-sulfate sulfatase deficiency

Head And Neck Neck:
short neck

Abdomen Gastrointestinal:
dysphagia
diarrhea
drooling

Head And Neck Nose:
anteverted nares
flat nasal bridge

Head And Neck Mouth:
wide mouth
drooling
thick lips

Skeletal Spine:
ovoid thoracolumbar vertebrae

Growth Height:
normal stature

Cardiovascular Heart:
asymmetric septal hypertrophy

Respiratory Nasopharynx:
frequent upper respiratory tract infections

Skeletal Limbs:
mild joint stiffness

Neurologic Behavioral Psychiatric Manifestations:
severe behavioral problems beginning at 3 to 4 years of age

Clinical features from OMIM:

252940

UMLS symptoms related to Mucopolysaccharidosis, Type Iiid:


seizures, joint stiffness, diarrhea

Drugs & Therapeutics for Mucopolysaccharidosis, Type Iiid

Search Clinical Trials , NIH Clinical Center for Mucopolysaccharidosis, Type Iiid

Genetic Tests for Mucopolysaccharidosis, Type Iiid

Anatomical Context for Mucopolysaccharidosis, Type Iiid

MalaCards organs/tissues related to Mucopolysaccharidosis, Type Iiid:

42
Bone, Eye, Skin, Liver

Publications for Mucopolysaccharidosis, Type Iiid

Articles related to Mucopolysaccharidosis, Type Iiid:

# Title Authors Year
1
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. ( 28334745 )
2017
2
Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations. ( 20232353 )
2010
3
Diagnosis of caprine mucopolysaccharidosis type IIID by real-time polymerase chain reaction-based genotyping. ( 20622237 )
2010
4
A novel loss-of-function mutation in the GNS gene causes Sanfilippo syndrome type D. ( 19650410 )
2009
5
Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene. ( 17998446 )
2007
6
Sanfilippo syndrome type D: identification of the first mutation in the N-acetylglucosamine-6-sulphatase gene. ( 12624138 )
2003
7
Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase. ( 12573255 )
2003
8
Sanfilippo syndrome type D. ( 3100754 )
1987
9
Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. ( 6450420 )
1980

Variations for Mucopolysaccharidosis, Type Iiid

UniProtKB/Swiss-Prot genetic disease variations for Mucopolysaccharidosis, Type Iiid:

76
# Symbol AA change Variation ID SNP ID
1 GNS p.Ser94Ile VAR_064070
2 GNS p.Lys340Arg VAR_064072
3 GNS p.Gly418Glu VAR_064073

ClinVar genetic disease variations for Mucopolysaccharidosis, Type Iiid:

6 (show all 22)
# Gene Variation Type Significance SNP ID Assembly Location
1 GNS NM_002076.3(GNS): c.1063C> T (p.Arg355Ter) single nucleotide variant Pathogenic rs119461974 GRCh37 Chromosome 12, 65130819: 65130819
2 GNS NM_002076.3(GNS): c.1063C> T (p.Arg355Ter) single nucleotide variant Pathogenic rs119461974 GRCh38 Chromosome 12, 64737039: 64737039
3 GNS NM_002076.3(GNS): c.1169delA (p.Gln390Argfs) deletion Pathogenic rs483352898 GRCh37 Chromosome 12, 65122767: 65122767
4 GNS NM_002076.3(GNS): c.1169delA (p.Gln390Argfs) deletion Pathogenic rs483352898 GRCh38 Chromosome 12, 64728987: 64728987
5 GNS NM_002076.3(GNS): c.1168C> T (p.Gln390Ter) single nucleotide variant Pathogenic rs119461975 GRCh37 Chromosome 12, 65122768: 65122768
6 GNS NM_002076.3(GNS): c.1168C> T (p.Gln390Ter) single nucleotide variant Pathogenic rs119461975 GRCh38 Chromosome 12, 64728988: 64728988
7 GNS NM_002076.3(GNS): c.1138_1139insGTCCT (p.Asp380Glyfs) insertion Pathogenic rs483352899 GRCh37 Chromosome 12, 65122797: 65122798
8 GNS NM_002076.3(GNS): c.1138_1139insGTCCT (p.Asp380Glyfs) insertion Pathogenic rs483352899 GRCh38 Chromosome 12, 64729017: 64729018
9 GNS NM_002076.3(GNS): c.1226_1227insG (p.Ser410Ilefs) insertion Pathogenic rs483352900 GRCh37 Chromosome 12, 65116868: 65116868
10 GNS NM_002076.3(GNS): c.1226_1227insG (p.Ser410Ilefs) insertion Pathogenic rs483352900 GRCh38 Chromosome 12, 64723088: 64723088
11 GNS NM_002076.3(GNS): c.198G> A (p.Pro66=) single nucleotide variant Benign rs1147096 GRCh37 Chromosome 12, 65146532: 65146532
12 GNS NM_002076.3(GNS): c.198G> A (p.Pro66=) single nucleotide variant Benign rs1147096 GRCh38 Chromosome 12, 64752752: 64752752
13 GNS NM_002076.3(GNS): c.363G> A (p.Lys121=) single nucleotide variant Benign/Likely benign rs2230291 GRCh37 Chromosome 12, 65141588: 65141588
14 GNS NM_002076.3(GNS): c.363G> A (p.Lys121=) single nucleotide variant Benign/Likely benign rs2230291 GRCh38 Chromosome 12, 64747808: 64747808
15 GNS NM_002076.3(GNS): c.1598G> A (p.Arg533His) single nucleotide variant Benign rs61743822 GRCh37 Chromosome 12, 65110582: 65110582
16 GNS NM_002076.3(GNS): c.1598G> A (p.Arg533His) single nucleotide variant Benign rs61743822 GRCh38 Chromosome 12, 64716802: 64716802
17 GNS NM_002076.3(GNS): c.253-10delT deletion Benign/Likely benign rs201654719 GRCh37 Chromosome 12, 65141708: 65141708
18 GNS NM_002076.3(GNS): c.253-10delT deletion Benign/Likely benign rs201654719 GRCh38 Chromosome 12, 64747928: 64747928
19 GNS NM_002076.3(GNS): c.688G> A (p.Ala230Thr) single nucleotide variant Uncertain significance GRCh37 Chromosome 12, 65137025: 65137025
20 GNS NM_002076.3(GNS): c.688G> A (p.Ala230Thr) single nucleotide variant Uncertain significance GRCh38 Chromosome 12, 64743245: 64743245
21 MOK NM_014226.2(MOK): c.630_631dup (p.Ile211Lysfs) duplication Uncertain significance GRCh38 Chromosome 14, 102233749: 102233750
22 MOK NM_014226.2(MOK): c.630_631dup (p.Ile211Lysfs) duplication Uncertain significance GRCh37 Chromosome 14, 102700086: 102700087

Expression for Mucopolysaccharidosis, Type Iiid

Search GEO for disease gene expression data for Mucopolysaccharidosis, Type Iiid.

Pathways for Mucopolysaccharidosis, Type Iiid

GO Terms for Mucopolysaccharidosis, Type Iiid

Sources for Mucopolysaccharidosis, Type Iiid

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....